<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: Ras oncogene mutations are the most frequently observed genetic abnormality (20-40% of patients) in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), and in the preleukemic conditions <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We have previously shown that mutant N-ras (N-rasm) can induce <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a murine reconstitution system </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study we investigated the effect of N-rasm in human primary hematopoietic progenitor cells (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Cord blood CD34+ hematopoietic progenitor cells (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e>) were transduced with retroviral vectors containing green fluorescence protein (GFP) alone, or in combination with N-rasm </plain></SENT>
<SENT sid="4" pm="."><plain>Cells were then cultured in vitro with a cytokine supplement or cocultured with murine stroma MS-5 cells </plain></SENT>
<SENT sid="5" pm="."><plain>The in vivo behavior of transduced cells was examined in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>/<z:mp ids='MP_0002536'>SCID</z:mp> mouse model </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: N-rasm-transduced cells exhibited greater proliferative capacity; a higher frequency of granulocyte-macrophage colony-forming unit (CFU-GM); and an increase in myelomonocytic lineage cells with a concomitant decrease in lymphoid and erythroid cells </plain></SENT>
<SENT sid="7" pm="."><plain>Analysis of transduced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>/<z:mp ids='MP_0002536'>SCID</z:mp> mice revealed higher bone marrow engraftment by N-rasm <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e> and increased numbers of myeloid lineage cells </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The results demonstrate that N-rasm in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e> induces myeloproliferation both in vitro and in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>/<z:mp ids='MP_0002536'>SCID</z:mp> mouse model as a primary event that does not appear to be dependent on cooperating transforming events </plain></SENT>
</text></document>